Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Cardiology Coronary Heart Disease

Coronary Heart Disease

MicroRNAs in diabetic macroangiopathy

Diabetic macroangiopathy is a leading cause of diabetes-related mortality. Could miRNAs improve the future outlook for diabetes patients? Learn about miRNA biogenesis and their functions in diabetic macroangiopathy to find out.

Read more

Editor's Choice

Semaglutide reduces obesity-related MACE risk despite kidney impairment

SELECT trial shows semaglutide reduces the risk for major adverse cardiovascular events in people with overweight or obesity regardless of kidney function impairment.

CPAP treatment for sleep apnea and CV outcomes

CPAP therapy has an important role in the holistic management of obstructive sleep apnea, extending beyond respiratory symptom relief to encompass cardiovascular health benefits. But treatment adherence is crucial.

Managing gout and metabolic syndrome

Gout is associated with metabolic syndrome and its related comorbid conditions. Find out more about the clinical challenge that is managing both conditions in the same patient.

Cardiometabolic effects of hypoprolactinemia

Hypoprolactinemia has only recently been described as a morbid entity. What’s known about its effect on bodyweight, the gluco-insulinemic and lipid profile, and cardiovascular outcomes?

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Latest News

De-escalating from DAPT to ticagrelor monotherapy does not increase ischemic risk after PCI

Drug-eluting stent remains the preferred treatment for de novo CAD

Semaglutide reduces obesity-related MACE risk despite kidney impairment

OCT aids stent placement in complex coronary artery lesions

High lipoprotein(a) levels increase risk of coronary disease progression

Sex does not impact aspirin efficacy for secondary ASCVD prevention

Case Studies

A complicated massive pulmonary arteriovenous fistula

Pulmonary arteriovenous fistula is a rare type of cyanotic pulmonary vascular malformation with right-to-left shunt. This case reports co-presentation in a patient with atherosclerotic heart disease.  

Syncope due to coronary artery spasm

Ischemia without obstructive coronary artery disease can be difficult to identify. In this case, the patient presented with recurrent syncope which was caused by coronary artery spasm microvascular dysfunction and effectively treated.

How to diagnose mediastinal angiosarcoma

A mediastinal angiosarcoma presented mimicking signs of constrictive pericarditis, aortic dissection, and coronary artery disease. The correct diagnosis only was made measurement of hyaluronic acid concentration in the pleural fluid.

Episode 3: Unravelling resistant hypertension

Why is it so difficult to diagnose and manage?

Resistant hypertension is a difficult to treat and often misunderstood phenomenon that continues to frustrate cardiologists. 

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options.

Prof. Morris Brown
Prof. Bryan Williams
Listen now

Current Reviews

Healthy Lifestyle and Cardiac Rehabilitation for Weight Loss

  • Obesity
  • Cardiometabolic Disease (DM and CV) (CJ Lavie, Section Editor)

Substantial recent attention has been directed at new pharmacological agents that produce significant weight loss, especially the glucagon-like peptide 1 (GLP-1) receptor agonists, such as semaglutide, and the glucose-dependent insulinotropic …

Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?

Cardiovascular disease (CVD) remains the leading cause of death in the United States [ 1 ]. Atherosclerosis is a complex process that involves many genetic loci, as well as multiple environmental and behavioral risk factors [ 2 ]. National …

Effects of Different Exercise Interventions on Cardiorespiratory Fitness, as Measured by Peak Oxygen Consumption in Patients with Coronary Heart Disease: An Overview of Systematic Reviews

Coronary heart disease (CHD) is a major cause of death worldwide [ 1 , 2 ]. People living with CHD have reduced cardiorespiratory fitness and poorer health-related quality of life when compared with healthy controls [ 3 , 4 ]. Cardiorespiratory …

Drug Interactions between Traditional Chinese Medicines and Cardiovascular Drugs

Cardiovascular disease (CVD) is one of the leading causes of death worldwide, and its internal medicine treatments are mostly single/few-target chemical drugs. Long-term use of cardiovascular drugs for complex chronic diseases may lead to serious …

Keynote webinar | Spotlight on cardio-oncology

  • Webinar | 16-05-2023 | 17:30 (CEST)

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Watch now

Further Reading

Selective FFRCT testing in suspected stable angina in clinical practice - initial experiences

Coronary CT angiography (CTA) derived fractional flow reserve (FFRCT) is recommended for physiological assessment in intermediate coronary stenosis for guiding referral to invasive coronary angiography (ICA). In this study, we report real-world …

The association between gout and subsequent cardiovascular events: a retrospective cohort study with 132,000 using propensity score matching in primary care outpatients in Germany

  • Open Access
  • Gout
  • Original Paper

Both the risk of developing heart disease and the course of the disease are determined in particular by comorbidities [ 1 , 2 ]. In this context, gout has recently been identified as an important factor in influencing the development of …

Television Viewing from Young Adulthood to Middle Age and Premature Cardiovascular Disease Events: A Prospective Cohort Study

Cardiovascular disease (CVD) is the leading cause of death in the United States (US), with >130 million US adults (45.1%) projected to have CVD by 2035. 1 Young adulthood represents an under-researched developmental period when individuals develop …

Sex ratio at birth across 100 years in Sweden and risk of cardiovascular disease and all-cause mortality – a national register study

The human sex ratio at birth (SRB) undergoes temporary changes around a mean proportion of 0.51 male births. SRB has been well studied for historical, geographical, and secular trends, but until now not linked to health outcomes in the total …

Image Credits